Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Third party research

I-tech: Customer slowdown tempers growth - ABG

I-tech

This is a third party research report and does not necessarily reflect our views or values

Download report (PDF)
* Q3 softer due to sizeable customer trimming '25 volumes* '25e-'27e sales cut by 11-6% and '26e-'27e EBIT by 12-8%* We believe I-Tech remains strongly positioned to grow market shareGrowth dampened by customer volume cutsI-Tech reported weaker than expected Q3 sales of SEK 41m (-18% vs. ABGSCe, +0.5% y-o-y, +10% org.) and EBIT of SEK 11m (vs. ABGSCe at 16m, +18% y-o-y) for a margin of 27% (23%). The weaker growth was mainly due to a key customer reducing its planned volumes for '25 due to financial constraints. On a positive note, the gross margin continued to improve, to 57% (52%), although it decreased slightly sequentially due to changes in the customer and producer mix. Looking ahead, management anticipates further improvements through margin-enhancing initiatives.Estimate changes and outlookWe cut '25e-'27e sales by 11-6% and '26e-'27e EBIT by 12-8%. While we expect continued growth among I-Tech’s other customers, including CMP, PPG, Jotun, and Kansai Paints, to partially offset the reduced volumes from the sizeable customer, we still anticipate a net negative impact on '25e- organic growth. Consequently, we lower our '25e organic growth to 5% (previously 18%). For '26e we expect we expect a partial recovery in the customer's volumes and for continued growth among smaller customers to support +25% organic growth.Trading at '25e-'27e EV/EBIT of 20x-8xAlthough we have lowered our estimates, we still anticipate that I-Tech will continue to increase its market share driven by growth among other customers and additional product launches. I-Tech expects to announce new strategic collaborations in the coming quarters. The company is actively developing opportunities both directly linked to Selektope, aimed at expanding its use through new formulations and customer products, and in adjacent technologies such as complementary additives and binder systems. The company is trading at 20x-8x EV/EBIT on '25e-'27e, and 25x-13x P/E, i.e. ~50-30% below the peer median.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.